Complex containing oligonucleotide having immunopotentiating activity and use thereof
US11015202B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 20, 2018 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Dec 20, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an oligodeoxynucleotide containing humanized K type CpG oligodeoxynucleotide and poly deoxyadenylate, wherein the poly deoxyadenylate is placed on the 3′-side of the humanized K type CpG oligodeoxynucleotide. In addition, the present invention provides a complex containing the aforementioned oligodeoxynucleotide and β-1,3-glucan.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.